The Journal of Maternal-Fetal & Neonatal Medicine · 2018 · 32 citations · 29 references
Veterinary MedicineImmunologyPathologyClinical ImmunologyInflammationPediatric ImmunologyAcute InflammationGastrointestinal InflammationInflammation In Preterm BirthC-reactive Protein TestingControl Group DesignInflammation-related BiomarkersMatched Control GroupNecrotizing InflammationSystemic Inflammation Markers
Objectives: To ascertain the diagnostic value of endocan and interleukin (IL)-33 in infants with necrotizing enterocolitis (NEC) and to compare their effectiveness with C-reactive protein (CRP) and interleukin-6 (IL-6).Methods: Eighty-four preterm infants including control (n = 42) and NEC (n = 42) were eligible. Blood samples were obtained from infants in the NEC for the assessment of CRP, IL-6, endocan, and IL-33 serum levels at the time of diagnosis (first day), at the third and seventh days of NEC. Endocan, IL-33, CRP, and IL-6 serum levels were measured at the 14th day of life in the control group.Results: Serum levels of endocan, IL-33, CRP, and IL-6 were significantly higher in the NEC group compared to the control group at the first, third, and seventh days (p < .05). IL-33 and endocan levels continued to rise in the consequent days in patients with stage III NEC (p < .05). Serum endocan and IL-33 levels gradually increased in patients who underwent surgery (p < .05). Serum endocan levels were higher in patients with stage III NEC than those in the stage II NEC at the diagnosis.Conclusions: Serum levels of IL-33 and endocan can be used as markers in the diagnosis and follow-up of NEC.
29
Neonatal Necrotizing Enterocolitis
Martin Bell, Jessie L. Ternberg, Ralph D. Feigin et al. · Annals of Surgery · 1978 · 3.5K citations · Full text
Medicine, Microbiology, Pediatrics +12
Luca Pastorelli, Rekha Garg, Sharon B. Hoang et al. · Proceedings of the National Academy of Sciences · 2010 · 411 citations · Full text
Life Sciences, Immunology, Pathology +17